DisGeNET
DisGeNET is a knowledge management platform that integrates and standardizes the data of genes and mutations related to diseases from multiple sources. It covers entire range of human disease.
| Database | Last Updated |
|---|---|
| DisGeNET | February 14, 2024 |
| Disease ID | Disease Name | Gene Symbol | Gene ID | Gene Name | UniProt ID ▲ |
|---|---|---|---|---|---|
|
Bladder Neoplasm
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
||||
|
Malignant Neoplasms
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
||||
|
Carcinoma of bladder
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
||||
|
Primary malignant neoplasm
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
||||
|
Malignant neoplasm of urinary bladder
|
ABO, alpha 1-3-N-acetylgalactosaminyltransferase and alpha 1-3-galactosyltransferase
|
||||
|
Chronic Lymphocytic Leukemia
|
phospholipase C gamma 2
|
||||
|
Dermatomyositis, Childhood Type
|
phospholipase C gamma 2
|
||||
|
Neoplasms
|
galectin 3
|
||||
|
Malignant neoplasm of prostate
|
galectin 3
|
||||
|
Prostatic Neoplasms
|
galectin 3
|
Displaying entries 351 - 360 of 1194 in total
To see the latest features, please visit our beta site.
International Collaboration
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Acknowledgements
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
